Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo-controlled, randomized phase Ib study.

D'Hondt, V

Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo-controlled, randomized phase Ib study. [electronic resource] - Blood May 1995 - 2347-53 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0006-4971


Acute-Phase Proteins--biosynthesis
Adult
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Bone Marrow--pathology
Carboplatin--administration & dosage
Cyclophosphamide--administration & dosage
Female
Fever--chemically induced
Headache--chemically induced
Humans
Immunologic Factors--adverse effects
Interleukin-6--adverse effects
Megakaryocytes--drug effects
Middle Aged
Ovarian Neoplasms--blood
Platelet Count--drug effects
Ploidies
Premedication
Recombinant Proteins--adverse effects
Safety
Thrombocytopenia--chemically induced